ロード中...
iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy
BACKGROUND: Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Identification of biomarkers for diabetic nephropathy for early diagnosis may be the key to avoiding damage from this condition. METHODS: Proteomic iTRAQ technology was first used to identify differenti...
保存先:
| 出版年: | Clin Proteomics |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668123/ https://ncbi.nlm.nih.gov/pubmed/31384238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-019-9253-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|